Luc Dochez

Managing Partner at DROIA Genetic Disease Fund

Droia invests globally in young drug development companies that use novel science and innovative approaches to bring promising therapies to patients. We are specialists, investing exclusively in therapeutics for oncology and genetic disease.

Dirk Standaert

CEO of BAR.ON

Beer is a beautiful product. Steeped in tradition, heritage and centuries of craftsmanship. No wonder it’s the biggest alcoholic beverage in the business.